Centiva Capital, LP Ionis Pharmaceuticals Inc Call Options Transaction History

Centiva Capital, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 17, 2022	BUY	$31.71 - $43.0 $117,327 - $159,100	3,700 New	3,700 $137,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $1.79 Million - $2.73 Million	-43,100 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $2.55 Million - $3.11 Million	43,100 New	43,100 $2.58 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.